NOTCH2 and cancer: However, while GSIs exhibit anti‐cancer effects, they are not specific for a particular Notch receptor, inhibit other signaling pathways, and cause intestinal toxicity, likely due to dual inhibition of NOTCH1 and NOTCH2.32